Table 4.
Average resting membrane potential of IJPs in treatment groups
| Treatment Groups | Values, mV | n |
|---|---|---|
| Healthy | ||
| WT | −46.00 ± 1.38 | 4 males, 4 females |
| Entpd1−/− | −48.99 ± 1.30 | 4 males, 3 females |
| Entpd2−/− | −48.31 ± 1.49 | 4 males, 5 females |
| DSS-treated | ||
| WT | −45.27 ± 0.99 | 4 males, 3 females |
| Entpd1−/− | −48.75 ± 2.30 | 4 males, 4 females |
| Entpd2−/− | −44.65 ± 1.40 | 4 males, 4 females |
Values are means ± SE. WT, wild type; DSS, dextran sulfate sodium; IJPs, inhibitory junction potentials. Differences between genotype, treatment, or their interaction were not significant [two-way ANOVA for genotype (F2,41 = 1.531, P = 0.359), treatment (F1,41 = 0.859, P = 0.229), and their interaction (F2,41 = 1.241, P = 0.3)].